UTI AMC

Why is UTI Asset Management Company Ltd falling/rising?

As of 31-Aug, UTI Asset Management Company Ltd's stock price is Rs. 871.00, down 1.91%, and has significantly underperformed the Sensex with a year-to-date decline of 22.85%. The stock is currently at a 52-week low and shows a bearish trend, compounded by decreased investor participation.

As of 31-Aug, UTI Asset Management Company Ltd's stock price is falling, currently at Rs. 871.00, reflecting a decrease of Rs. 17.0 or 1.91%. The stock has been underperforming relative to the benchmark Sensex, with a decline of 1.81% over the past week compared to a 0.53% drop in the index. Over the last month, the stock has decreased by 3.60%, while the Sensex has only fallen by 1.46%. Year-to-date, the stock has experienced a significant decline of 22.85%, compared to a 9.70% drop in the benchmark.<BR><BR>Today, the stock reached a new 52-week low of Rs. 866.45 and has been on a consecutive downward trend for the last three days, accumulating a total decline of 3.14% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Investor participation has also decreased, with delivery volume falling by 38.32% compared to the 5-day average.<BR><BR>Despite some positive factors, such as a high dividend yield of 4.51% and strong long-term fundamentals, the stock's recent performance and declining investor interest contribute to its current downward trajectory.

Who are in the management team of UTI AMC?

The management team of UTI AMC includes Imtaiyazur Rahman (Managing Director), D K Mehrotra (Chairman & Independent Director), and several other directors and independent directors, totaling 12 key members with diverse expertise.

The management team of UTI AMC includes the following individuals:<BR><BR>1. **Imtaiyazur Rahman** - Managing Director<BR>2. **Flemming Madsen** - Director<BR>3. **Narasimhan Seshadri** - Independent Director<BR>4. **Deepak Kumar Chatterjee** - Independent Director<BR>5. **Dipali H Sheth** - Independent Director<BR>6. **Edward Cage Bernard** - Director<BR>7. **Jayashree Vaidhyanthan** - Independent Director<BR>8. **Rajeev Kakar** - Independent Director<BR>9. **D K Mehrotra** - Chairman & Independent Director<BR>10. **Arvind Bhagwan Das Patkar** - Company Secretary & Compliance Officer<BR>11. **Kiran Kumar Tarania** - Nominee<BR>12. **Srivatsa Desikamani** - Nominee<BR><BR>This team brings a diverse range of expertise and leadership to the company.

What does UTI AMC do?

UTI Asset Management Company Ltd specializes in managing mutual funds, private equity, and portfolio management services for individual and institutional investors. As of June 2026, it reported net sales of 584 Cr and a net profit of 294 Cr, with a market cap of INR 11,338 Cr.

Overview:<BR>UTI Asset Management Company Ltd is a small-cap firm in the capital markets industry, specializing in managing private equity and venture funds, mutual funds, portfolio management services, and retirement solutions for both individual and institutional investors.<BR><BR>History:<BR>The company was incorporated on November 14, 2002, and later converted to a public limited company, officially changing its name to UTI Asset Management Company Limited on November 14, 2007. The most recent quarterly results reported net sales and net profit for June 2026.<BR><BR>Financial Snapshot:<BR>- Net Sales: 584 Cr (Quarterly Results - Jun 2026)<BR>- Net Profit: 294 Cr (Quarterly Results - Jun 2026)<BR>- Market Cap: INR 11,338 Cr (Small Cap)<BR><BR>Key Metrics:<BR>- P/E: 21.00<BR>- Industry P/E: 21<BR>- Dividend Yield: 4.51%<BR>- Debt-Equity: 0.03<BR>- Return on Equity: 10.84%<BR>- Price to Book: 2.53<BR><BR>Contact Details:<BR>No Company Details Available. Registrar Address: Not available.

Who are the peers of the UTI AMC?

UTI AMC's peers include Angel One, Cams Services, NSDL, KFin Technologies, Prudent Corp, Indian Energy Exchange, IIFL Capital, CARE Ratings, and ICRA. UTI AMC has a good management risk rating, but its 1-year return is -32.36%, better than NSDL's -34.39%.

Peers: The peers of UTI AMC are Angel One, Cams Services, N S D L, KFin Technolog., Prudent Corp, Indian Energy Ex, IIFL Capital, CARE Ratings, and ICRA.<BR><BR>Quality Snapshot: Excellent management risk is observed at Angel One, Cams Services, KFin Technolog., Prudent Corp, and Indian Energy Ex, while Average management risk is found at N S D L and IIFL Capital, and Good management risk is noted for UTI AMC, CARE Ratings, and ICRA. Growth is rated as Good for Angel One, KFin Technolog., and Prudent Corp, while Below Average growth is seen at Cams Services, UTI AMC, Indian Energy Ex, and the rest. All peers maintain an Excellent capital structure.<BR><BR>Return Snapshot: Prudent Corp has the highest 1-year return at 30.08%, while N S D L has the lowest at -34.39%, with UTI AMC's 1-year return at -32.36%, indicating a performance slightly better than N S D L. Additionally, KFin Technolog., Indian Energy Ex, and ICRA have negative six-month returns.

How big is UTI AMC?

As of 31st August, UTI Asset Management Company Ltd has a market capitalization of 11,338.00 Cr, with recent net sales of 1,909.47 Cr and a net profit of 461.13 Cr. The company has shareholder's funds of 4,504.63 Cr and total assets of 5,043.38 Cr as of March 2026.

As of 31st August, UTI Asset Management Company Ltd has a market capitalization of 11,338.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, UTI AMC reported Net Sales of 1,909.47 Cr and a Net Profit of 461.13 Cr.<BR><BR>For the latest annual period ending in March 2026, the company has Shareholder's Funds amounting to 4,504.63 Cr and Total Assets of 5,043.38 Cr.

Which are the latest news on UTI AMC?

Are UTI Asset Management Company Ltd latest results good or bad?

UTI Asset Management Company Ltd's latest results for Q1 FY27 show a strong recovery with a net profit of ₹293.86 crore, up 540.50% quarter-on-quarter. However, concerns about its return on equity and underperformance compared to peers suggest cautious market sentiment despite the positive operational metrics.

UTI Asset Management Company Ltd's latest results for Q1 FY27 indicate a strong recovery following a challenging previous quarter. The company reported a net profit of ₹293.86 crore, which is a significant turnaround from a loss of ₹66.71 crore in Q4 FY26, marking a remarkable 540.50% increase quarter-on-quarter. Year-on-year, the net profit also shows a healthy growth of 24.07%.<BR><BR>Revenue for the quarter reached ₹583.51 crore, up 49.51% from the previous quarter and 6.70% year-on-year. The operating margin has improved to 65.56%, which is a record high for the company, reflecting effective cost management and operational efficiency.<BR><BR>However, despite these positive results, there are concerns regarding the company's return on equity (ROE), which stands at 10.84%, below the average for the sector. Additionally, UTI AMC has underperformed compared to its peers, with a significant decline in stock price over the past year.<BR><BR>In summary, while the latest results show strong operational metrics and a recovery from previous losses, the overall market sentiment remains cautious due to concerns about long-term growth and capital efficiency.

Should I buy, sell or hold UTI Asset Management Company Ltd?

Is UTI AMC technically bullish or bearish?

As of November 19, 2025, the technical trend is mildly bearish, indicated by bearish signals from MACD, Bollinger Bands, KST, and OBV across weekly and monthly time frames, despite a mildly bullish daily moving average.

As of 19 November 2025, the technical trend has changed from sideways to mildly bearish. The current technical stance is mildly bearish, driven by several key indicators. The MACD is mildly bearish on both the weekly and monthly time frames, while Bollinger Bands also indicate a bearish trend on both time frames. The KST and OBV are both mildly bearish weekly and monthly as well. Although the daily moving averages show a mildly bullish signal, the overall sentiment remains bearish due to the prevailing trends in the longer time frames. The stock has underperformed compared to the Sensex over the past month and year, further supporting the bearish outlook.

How has been the historical performance of UTI AMC?

UTI AMC has shown consistent growth in net sales and profits, with net sales rising from 1,266.86 Cr in March 2023 to 1,851.09 Cr in March 2025, and operating profit increasing to 1,110.42 Cr. However, earnings per share decreased slightly from 60.17 in March 2024 to 57.16 in March 2025, despite overall profit growth.

Answer:<BR>The historical performance of UTI AMC shows a consistent growth trend in net sales and profit over the years, with net sales reaching 1,851.09 Cr in March 2025, up from 1,736.96 Cr in March 2024 and significantly higher than 1,266.86 Cr in March 2023. Operating profit (PBDIT) also increased to 1,110.42 Cr in March 2025 from 1,040.37 Cr in March 2024, indicating improved operational efficiency. Profit before tax rose to 1,052.17 Cr in March 2025, compared to 986.84 Cr in the previous year, while profit after tax was 812.96 Cr, slightly up from 802.03 Cr in March 2024. The company's earnings per share (EPS) decreased to 57.16 in March 2025 from 60.17 in March 2024, reflecting a slight decline in profitability per share despite the overall profit growth. <BR><BR>Breakdown:<BR>Over the years, UTI AMC has demonstrated a robust growth trajectory in its financial performance. From March 2020 to March 2025, net sales have increased from 854.03 Cr to 1,851.09 Cr, showcasing a strong upward trend. Operating profit has also seen a significant rise, moving from 348.31 Cr in March 2020 to 1,110.42 Cr in March 2025, indicating enhanced operational efficiency. Profit before tax has followed suit, climbing from 341.30 Cr in March 2020 to 1,052.17 Cr in March 2025. However, the profit after tax has shown a more modest increase, reaching 812.96 Cr in March 2025, up from 802.03 Cr in March 2024. The company's earnings per share peaked in March 2024 at 60.17 but fell to 57.16 in March 2025. Overall, UTI AMC's financial metrics reflect a solid performance with increasing revenues and profits, despite some fluctuations in profitability per share.

Is UTI AMC overvalued or undervalued?

As of October 23, 2025, UTI AMC's stock is considered attractive and undervalued with a PE ratio of 28.68, significantly lower than peers like Bajaj Finance, and despite a year-to-date return of -1.86%, it has outperformed the Sensex over the last three years with a return of 73.81%.

As of 23 October 2025, the valuation grade for UTI AMC has moved from fair to attractive, indicating a more favorable assessment of the company's stock. The company is currently considered undervalued. Key ratios include a PE ratio of 28.68, an EV to EBITDA of 13.80, and a Price to Book Value of 0.38, which suggest that the stock is trading at a discount relative to its intrinsic value.<BR><BR>In comparison with peers, UTI AMC's PE ratio of 28.68 is significantly lower than that of Bajaj Finance at 39.07, which is categorized as very expensive, while Life Insurance, rated very attractive, has a PE of 11.68. The company's recent performance has been mixed, with a year-to-date return of -1.86% compared to the Sensex's 8.21%, but over the last three years, UTI AMC has outperformed the Sensex with a return of 73.81% versus 42.57%.

Who are the top shareholders of the UTI AMC?

The top shareholders of UTI AMC include T. Rowe Price International Ltd with 22.79%, 23 mutual fund schemes holding 13.14%, and 178 foreign institutional investors with 7.85%. Individual investors account for 7.44%, with no pledged promoter holdings reported.

The top shareholders of UTI AMC include T. Rowe Price International Ltd, which holds a significant 22.79% of the shares. Additionally, the company has 23 mutual fund schemes collectively holding 13.14% and 178 foreign institutional investors (FIIs) with a combined holding of 7.85%. Individual investors also account for 7.44% of the shareholding. Notably, there are no pledged promoter holdings and no specific promoter with the highest holding mentioned.

When is the next results date for UTI AMC?

No Upcoming Board Meetings

Has UTI AMC declared dividend?

Yes, UTI Asset Management Company Ltd has declared a 240% dividend, amounting to ₹24 per share, with an ex-date of July 18, 2024. The dividend yield is 3.96%, and total returns have shown strong performance over longer periods despite a recent decline.

UTI Asset Management Company Ltd has declared a 240% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 240%<BR>- Amount per share: 24 <BR>- Ex-date: 18 Jul 24<BR><BR>Dividend Yield: 3.96%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -7.18%, with a dividend return of 0%, resulting in a total return of -7.18%.<BR><BR>Over the past year, the price return was 28.15%, the dividend return was 2.44%, leading to a total return of 30.59%.<BR><BR>In the 2-year period, the price return was 68.05%, with a dividend return of 6.70%, culminating in a total return of 74.75%.<BR><BR>For the 3-year period, the price return was 86.97%, the dividend return was 10.74%, resulting in a total return of 97.71%.<BR><BR>In the last 4 years, the price return was 61.73%, with a dividend return of 9.68%, leading to a total return of 71.41%.<BR><BR>Over the past 5 years, the price return was 0%, with a dividend return of 0%, resulting in a total return of 0.0%.<BR><BR>Overall, UTI AMC has declared a significant dividend, and the total returns over various periods indicate strong performance, particularly in the longer terms, despite a recent downturn in the short term.